HansBiomed Corporation (042520) — Free Cash Flow Generation Index
HansBiomed Corporation (042520) has a Free Cash Flow Generation Index of 0.63x as of September 2025. Free cash flow of ₩756.94 Million represents 1% of operating cash flow (₩1.21 Billion). Explore 042520 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
HansBiomed Corporation Free Cash Flow Generation Index (2012–2025)
Historical FCF Generation Index trend for HansBiomed Corporation across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does HansBiomed Corporation generate cash.
Annual Free Cash Flow Generation for HansBiomed Corporation (2012–2025)
Year-by-year Free Cash Flow Generation Index for HansBiomed Corporation. Check 042520 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.52x | ₩-1.44 Billion | ₩318.34 Million | ₩1.76 Billion | ▼ -642.7% |
| 2024 | -0.61x | ₩-1.07 Billion | ₩1.76 Billion | ₩2.83 Billion | ▼ -2.8% |
| 2020 | -0.59x | ₩-3.41 Billion | ₩5.75 Billion | ₩7.05 Billion | ▼ -119.6% |
| 2019 | 3.02x | ₩23.28 Billion | ₩7.71 Billion | ₩15.56 Billion | ▲ +111.0% |
| 2018 | 1.43x | ₩7.44 Billion | ₩5.20 Billion | ₩2.24 Billion | ▼ -57.1% |
| 2017 | 3.33x | ₩18.64 Billion | ₩5.60 Billion | ₩13.05 Billion | ▲ +21.1% |
| 2015 | 2.75x | ₩9.54 Billion | ₩3.47 Billion | ₩6.07 Billion | ▼ -60.7% |
| 2014 | 7.01x | ₩14.45 Billion | ₩2.06 Billion | ₩12.39 Billion | ▲ +69.9% |
| 2013 | 4.13x | ₩9.62 Billion | ₩2.33 Billion | ₩7.29 Billion | ▲ +253.0% |
| 2012 | 1.17x | ₩1.75 Billion | ₩1.50 Billion | ₩253.56 Million | — |